Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
luvixasertib (CFI-402257)
i
Other names:
CFI-402257, 402257, 2257
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Treadwell Therap
Drug class:
TTK inhibitor
Related drugs:
‹
S81694 (2)
VRN08 (1)
BAL0891 (0)
NMS-153 (0)
BAY1161909 (0)
S81694 (2)
VRN08 (1)
BAL0891 (0)
NMS-153 (0)
BAY1161909 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
ER positive
HER2 Negative Breast Cancer
ER positive
HER2 Negative Breast Cancer
CFI-402257
Sensitive: B - Late Trials
CFI-402257
Sensitive
:
B
CFI-402257
Sensitive: B - Late Trials
CFI-402257
Sensitive
:
B
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login